Cargando…
Biochemical Changes in Blood of Patients with Duchenne Muscular Dystrophy Treated with Granulocyte-Colony Stimulating Factor
INTRODUCTION: In addition to the “gold standard” of therapy—steroids and gene therapy–there are experimental trials using granulocyte-colony stimulating factor (G-CSF) for patients with Duchenne muscular dystrophy (DMD). The aim of this study was to present the biochemical changes in blood after rep...
Autores principales: | Sienkiewicz, Dorota, Kułak, Wojciech, Paszko-Patej, Grażyna, Okurowska-Zawada, Bożena, Sienkiewicz, Jerzy, Kułak, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436375/ https://www.ncbi.nlm.nih.gov/pubmed/31001554 http://dx.doi.org/10.1155/2019/4789101 |
Ejemplares similares
-
Efficacy and the Safety of Granulocyte Colony-Stimulating Factor Treatment in Patients with Muscular Dystrophy: A Non-Randomized Clinical Trial
por: Sienkiewicz, Dorota, et al.
Publicado: (2017) -
Effect of Periodic Granulocyte Colony-Stimulating Factor Administration on Endothelial Progenitor Cells and Different Monocyte Subsets in Pediatric Patients with Muscular Dystrophies
por: Eljaszewicz, Andrzej, et al.
Publicado: (2016) -
Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy
por: Mirska, Anna, et al.
Publicado: (2018) -
Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)